Skip to main content

Clozapine News

FDA Makes Access to Clozapine Easier for Patients With Schizophrenia

FRIDAY, Feb. 28, 2025 – The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine. The...

FDA Medwatch Alert: Drug Safety Communication: Clozapine (Clozaril, Fazaclo ODT, Versacloz) - FDA Strengthens Warning That Untreated Constipation Can Lead to Serious Bowel Problems

ISSUE: FDA is strengthening an existing warning that constipation caused by the schizophrenia medicine clozapine (Clozaril, Fazaclo ODT, Versacloz, generics) can, uncommonly, progress to serious...

FDA Medwatch Alert: Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program

ISSUE: FDA is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, to address continuing safety concerns and current...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Borderline Personality Disorder, Schizophrenia, Paranoid Disorder

Clozapine patient information at Drugs.com